Drug Trial Radar · NCT05911217
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Jul 11, 2023
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- CARsgen Therapeutics Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Fudan University
- First posted
- Jun 20, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open-label, single-arm, multicenter, Phase Ib clinical trial to evaluate the efficacy and safety of CT041 Autologous CAR T Cell Injection after adjuvant chemotherapy in subjects with pancreatic cancer.
Conditions
- Pancreatic Cancer
Interventions
CT041 autologous CAR T-cell injectionDrug
Treatment with anti-claudin18.2 chimeric antigen receptor T-cell infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease free survival (DFS)Time frame: Up to 18 months
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Union Hospital, Tongji Medical College, Hua zhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Hunan Provincial People's Hospital
Changsha, Hunan, China · Recruiting
Ruijin Hospital, affiliated to Shanghai Jiaotong University, school of medicine
Shanghai, Shanghai Municipality, China · Recruiting
Fudan University Shanghai Cancer Hospital
Shanghai, Shanghai Municipality, China · Recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xian, Shanxi, China · Recruiting
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.